One of the most robust electrophysiological features of schizophrenia is reduced mismatch negativity, a component of the event related potential (ERP) induced by rare and unexpected stimuli in an otherwise regular pattern. Emerging evidence suggests that mismatch negativity (MMN) is not the only ERP index of deviance detection in the mammalian brain and that sensitivity to deviant sounds in a regular background can be observed at earlier latencies in both the human and rodent brain. Pharmacological studies in humans and rodents have previously found that MMN reductions similar to those seen in schizophrenia can be elicited by N-methyl-d-aspartate (NMDA) receptor antagonism, an observation in agreement with the hypothesised role of NMDA rece...
International audienceNMDAr antagonists acutely produces, in the rodent CNS, generalized aberrant ga...
Schizophrenia is associated with impairments in pre-attentive change detection, as represented by re...
Antagonists of N-methyl-D-aspartate receptors (NMDAR) have psychotomimetic effects in humans and are...
One of the most robust electrophysiological features of schizophrenia is reduced mismatch negativity...
Reductions in the size of the mismatch negativity (MMN), an event-related potential component elicit...
Mismatch Negativity (MMN) is an N-methyl-d-aspartic acid (NMDA)-mediated, negative deflection in hum...
International audienceThis article aims to provide a theoretical framework to elucidate the neurophy...
The capacity of the human brain to detect deviance in the acoustic environment pre-attentively is re...
Recent reviews and meta-analyses suggest that reducing the duration of untreated psychosis leads to ...
Evidence from clinical and preclinical studies implicates dysfunction of N-methyl-D-aspartate recept...
Impairments in mismatch negativity (MMN) generation have been consistently reported in patients with...
The psychotomimetics ketamine and MK-801, non-competitive NMDA receptor (NMDAr) antagonists, induce ...
Schizophrenia is associated with impairments in pre-attentive change detection, as represented by re...
NMDA-R hypofunctioninig is a core pathophysiological mechanism in schizophrenia. However, it is uncl...
Impairments in mismatch negativity (MMN) in schizophrenia are well-established; these findings have ...
International audienceNMDAr antagonists acutely produces, in the rodent CNS, generalized aberrant ga...
Schizophrenia is associated with impairments in pre-attentive change detection, as represented by re...
Antagonists of N-methyl-D-aspartate receptors (NMDAR) have psychotomimetic effects in humans and are...
One of the most robust electrophysiological features of schizophrenia is reduced mismatch negativity...
Reductions in the size of the mismatch negativity (MMN), an event-related potential component elicit...
Mismatch Negativity (MMN) is an N-methyl-d-aspartic acid (NMDA)-mediated, negative deflection in hum...
International audienceThis article aims to provide a theoretical framework to elucidate the neurophy...
The capacity of the human brain to detect deviance in the acoustic environment pre-attentively is re...
Recent reviews and meta-analyses suggest that reducing the duration of untreated psychosis leads to ...
Evidence from clinical and preclinical studies implicates dysfunction of N-methyl-D-aspartate recept...
Impairments in mismatch negativity (MMN) generation have been consistently reported in patients with...
The psychotomimetics ketamine and MK-801, non-competitive NMDA receptor (NMDAr) antagonists, induce ...
Schizophrenia is associated with impairments in pre-attentive change detection, as represented by re...
NMDA-R hypofunctioninig is a core pathophysiological mechanism in schizophrenia. However, it is uncl...
Impairments in mismatch negativity (MMN) in schizophrenia are well-established; these findings have ...
International audienceNMDAr antagonists acutely produces, in the rodent CNS, generalized aberrant ga...
Schizophrenia is associated with impairments in pre-attentive change detection, as represented by re...
Antagonists of N-methyl-D-aspartate receptors (NMDAR) have psychotomimetic effects in humans and are...